Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment. - Wikidata - awgldk - TriplyDB

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

http://www.wikidata.org/entity/Q37240748

about

Tumor necrosis factor‑α and interleukin‑6 suppress microRNA‑1275 transcription in human adipocytes through nuclear factor‑κB.Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials.Positron Emission Tomography as an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis.

P2860

Q40049654-49C1C654-7A8D-451E-AA61-0B30C0274C34 Q47158087-BD69B4DD-34B1-42CC-A1E8-5054AB18C55F Q47836073-9201EFCE-FE83-4DE1-AB3C-D471367EBE62

P2860

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

http://www.wikidata.org/entity/Q37240748

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@en

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@nl

type

label

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@en

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@nl

prefLabel

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@en

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@nl

P1433

Q37240748-532C03CA-0334-4CFD-9940-10D80B253F0E

P1476

Q37240748-6CACA50B-B72C-439E-BD44-F5F94CA81FAE

P2093

Q37240748-13CB4101-4E63-4AA6-A13E-20E1DC6242AF

Q37240748-19FF497E-2727-42E3-96FC-62D5F5A43D55

Q37240748-410B8D0D-EB6D-4CF5-8B0A-FE1DAA054ADC

Q37240748-4871D6BB-1324-4A48-BB96-2062E12B79B9

Q37240748-539EF30D-AB42-4F34-A6EA-078F5E56C119

Q37240748-6DE5FEEC-1C1B-4BE6-A96E-E5B8D9E124DF

Q37240748-7587489F-AB97-449A-BB83-BEF3AEA3F832

Q37240748-B0AC64BC-799D-4433-A2B9-CD1CBFCC6357

P2860

Q37240748-03F96589-3D4F-46C6-A9A1-39F91463AFC2

Q37240748-133F24D6-8EC2-4660-978D-E77917DFCE10

Q37240748-28F56565-20F1-4843-8E32-15627AA17C9C

Q37240748-2A8C1BD1-F733-4CDF-9143-A5A35D62827D

Q37240748-2E2421A0-2D31-4DA5-A595-F3CCDAF88947

Q37240748-36A5983E-DFDD-439D-BE00-9EC1EAC713C7

Q37240748-3F66D40D-68B6-457E-980B-35DFD5A59D56

Q37240748-44EE2BD3-CF38-487B-B93D-4CCE781486DA

Q37240748-4BD25CC5-D22F-4EDD-91D6-5F4915A5D601

Q37240748-4F454368-CC02-4F19-8B63-4FDD32132AF5

P31

Q37240748-064A22EB-BAC7-424E-BF33-71420E48C0E1

P356

Q37240748-B7612CB4-7626-4AB3-8C3B-19725DF9CFE9

P433

Q37240748-43FD1D97-B086-49E2-A39E-B18C8F4553B1

P478

Q37240748-DBE0622D-4E8C-4DAD-8BE1-31AAF81F34EF

P50

Q37240748-8766E78C-C9B4-4913-955E-4A5D38210AFF

P577

Q37240748-A58066C7-A5B6-43DA-B21B-5A39F975C00B

P698

Q37240748-B32B0CB5-8D96-4092-9DDD-9726147609BB

P921

Q37240748-03EB93D0-3B54-4B42-AE79-0570A3467AB0

Q37240748-A43D4B47-CB04-403F-B390-2FEC7FE0D061

P932

Q37240748-65FB6FC4-46C4-466C-8A09-BDB59479B1FA

P356

JAHA.116.003621

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.

@en

P2093

Christopher T Sibley

http://www.w3.org/2001/XMLSchema#string

Evrim B Turkbey

http://www.w3.org/2001/XMLSchema#string

João A C Lima

http://www.w3.org/2001/XMLSchema#string

Marissa Mallek

http://www.w3.org/2001/XMLSchema#string

Mark A Ahlman

http://www.w3.org/2001/XMLSchema#string

Shenghan Lai

http://www.w3.org/2001/XMLSchema#string

Songtao Liu

http://www.w3.org/2001/XMLSchema#string

Veit Sandfort

http://www.w3.org/2001/XMLSchema#string

P2860

Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

Ranolazine: A Contemporary Review

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

MRI-measured regression of carotid atherosclerosis induced by statins with and without niacin in a randomised controlled trial: the NIA plaque study.

Prediction of high-risk plaque development and plaque progression with the carotid atherosclerosis score

Coronary artery calcium score and risk classification for coronary heart disease prediction.

Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the multi-ethnic study of atherosclerosis (MESA).

P31

scholarly article

P356

10.1161/JAHA.116.003621

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

David A. Bluemke

P577

2016-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27413040

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5015399

http://www.w3.org/2001/XMLSchema#string